Search results for "Induced Pluripotent Stem Cells"

showing 10 items of 31 documents

Primary Cilium-Mediated Retinal Pigment Epithelium Maturation Is Disrupted in Ciliopathy Patient Cells

2018

SUMMARY Primary cilia are sensory organelles that protrude from the cell membrane. Defects in the primary cilium cause ciliopathy disorders, with retinal degeneration as a prominent phenotype. Here, we demonstrate that the retinal pigment epithelium (RPE), essential for photoreceptor development and function, requires a functional primary cilium for complete maturation and that RPE maturation defects in ciliopathies precede photoreceptor degeneration. Pharmacologically enhanced ciliogenesis in wild-type induced pluripotent stem cells (iPSC)-RPE leads to fully mature and functional cells. In contrast, ciliopathy patient-derived iPSC-RPE and iPSC-RPE with a knockdown of ciliary-trafficking pr…

0301 basic medicineRetinal degenerationInduced Pluripotent Stem CellsRespiratory MucosaRetinal Pigment EpitheliumBiologyCell MaturationCiliopathiesArticleGeneral Biochemistry Genetics and Molecular BiologyMice03 medical and health sciencesCiliogenesismedicineAnimalsCiliaInduced pluripotent stem celllcsh:QH301-705.5Mice KnockoutRetinal pigment epitheliumCiliumRetinal Degenerationmedicine.diseaseCiliopathieseye diseasesCell biologyProtein Kinase C-deltaCiliopathy030104 developmental biologymedicine.anatomical_structurelcsh:Biology (General)sense organsCell Reports
researchProduct

Use of Stem Cell Extracellular Vesicles as a “Holistic” Approach to CNS Repair

2020

Neurodegeneration is a hallmark of many diseases and disorders of the central nervous system (CNS). High levels of neuroinflammation are often associated with irreparable damage to CNS cells due to the dysregulation of signaling cascades that are unable to restore a homeostatic balance. Due to the inherent complexity of the CNS, development of CNS-related therapeutics has met limited success. While stem cell therapy has been evaluated in the context of CNS repair, the mechanisms responsible for their functional properties have not been clearly defined. In recent years, there has been growing interest in the use of stem cell extracellular vesicles (EVs) for the treatment of various CNS patho…

0301 basic medicineinduced pluripotent stem cellsmedicine.medical_treatmentContext (language use)ReviewexosomesBiologyNeuroprotectionCell and Developmental Biology03 medical and health sciences0302 clinical medicinemedicineInduced pluripotent stem celllcsh:QH301-705.5Neuroinflammationmesenchymal stem cellsMesenchymal stem cellCell BiologyStem-cell therapycentral nervous systemMicrovesicles030104 developmental biologylcsh:Biology (General)030220 oncology & carcinogenesisStem cellextracellular vesiclesNeuroscienceDevelopmental BiologyFrontiers in Cell and Developmental Biology
researchProduct

Reprogramming of Pericyte-Derived Cells of the Adult Human Brain into Induced Neuronal Cells

2012

SummaryReprogramming of somatic cells into neurons provides a new approach toward cell-based therapy of neurodegenerative diseases. A major challenge for the translation of neuronal reprogramming into therapy is whether the adult human brain contains cell populations amenable to direct somatic cell conversion. Here we show that cells from the adult human cerebral cortex expressing pericyte hallmarks can be reprogrammed into neuronal cells by retrovirus-mediated coexpression of the transcription factors Sox2 and Mash1. These induced neuronal cells acquire the ability of repetitive action potential firing and serve as synaptic targets for other neurons, indicating their capability of integrat…

AdultNeurogenesisCellular differentiationInduced Pluripotent Stem CellsAction PotentialsBiologySynaptic TransmissionMiceNeural Stem CellsSOX2Basic Helix-Loop-Helix Transcription FactorsGeneticsmedicineAnimalsHumansInduced pluripotent stem cellCells CulturedCerebral CortexNeuronsSOXB1 Transcription FactorsNeurogenesisCell DifferentiationNeurodegenerative DiseasesCell BiologyCellular ReprogrammingNeural stem cellCell biologyRetroviridaemedicine.anatomical_structureImmunologyMolecular MedicineNeuronPericyteNerve NetPericytesReprogrammingStem Cell TransplantationCell Stem Cell
researchProduct

Progerin expression induces a significant downregulation of transcription from human repetitive sequences in iPSC-derived dopaminergic neurons.

2019

Repetitive DNA sequences represent about half of the human genome. They have a central role in human biology, especially neurobiology, but are notoriously difficult to study. The purpose of this study was to quantify the transcription from repetitive sequences in a progerin-expressing cellular model of neuronal aging. Progerin is a nuclear protein causative of the Hutchinson–Gilford progeria syndrome that is also incrementally expressed during the normal aging process. A dedicated pipeline of analysis allowed to quantify transcripts containing repetitive sequences from RNAseq datasets oblivious of their genomic localization, tolerating a sufficient degree of mutational noise, all with low c…

AgingRetroelementsTranscription GeneticAluInduced Pluripotent Stem CellsAlu elementDown-RegulationSettore BIO/11 - Biologia MolecolareRetrotransposonComputational biologyBiologySettore BIO/19 - Microbiologia GeneraleProgerinProgeriaSettore BIO/13 - Biologia ApplicataAlu ElementsRepetitive sequencemedicineRetrotransposonHumansDNA transposonRepeated sequenceGeneCellular SenescenceProgeriaintegumentary systemDopaminergic NeuronsFibroblastsmedicine.diseaseProgerinLamin Type ASettore BIO/18 - GeneticaSatelliteHuman genomeOriginal ArticleGeriatrics and GerontologyGeroScience
researchProduct

Heart valve tissue engineering: how far is the bedside from the bench?

2015

Heart disease, including valve pathologies, is the leading cause of death worldwide. Despite the progress made thanks to improving transplantation techniques, a perfect valve substitute has not yet been developed: once a diseased valve is replaced with current technologies, the newly implanted valve still needs to be changed some time in the future. This situation is particularly dramatic in the case of children and young adults, because of the necessity of valve growth during the patient's life. Our review focuses on the current status of heart valve (HV) therapy and the challenges that must be solved in the development of new approaches based on tissue engineering. Scientists and physicia…

Aortic valveHeart diseaseSwine030204 cardiovascular system & hematology0302 clinical medicineHeart valve tissue engineeringHyaluronic AcidChildProsthetic valve0303 health sciencesMARROW-DERIVED CELLSTissue ScaffoldsFetal BloodHeart Valves3. Good healthmedicine.anatomical_structureHeart Valve ProsthesisCardiologyMolecular MedicineCollagenmedicine.medical_specialtyPULMONARY VALVEBONE-MARROWInduced Pluripotent Stem CellsVENTRICULAR OUTFLOW TRACTMESENCHYMAL STEM-CELLS03 medical and health sciencesTissue scaffoldsInternal medicineEXTRACELLULAR-MATRIXmedicineAnimalsHumansHeart valveIntensive care medicineENDOTHELIAL PROGENITOR CELLSMolecular Biology030304 developmental biologyBioprosthesisAORTIC-VALVEFibrinSheepTissue Engineeringbusiness.industryEndothelial Cellsmedicine.diseaseTransplantationPulmonary valveUMBILICAL-CORD BLOOD1182 Biochemistry cell and molecular biologybusinessHUMAN AMNIOTIC-FLUIDExpert Reviews in Molecular Medicine
researchProduct

Brains in metamorphosis: reprogramming cell identity within the central nervous system

2014

During embryonic development, uncommitted pluripotent cells undergo progressive epigenetic changes that lock them into a final differentiated state. Can mammalian cells change identity within the living organism? Direct lineage reprogramming of cells has attracted attention as a means to achieve organ regeneration. However, it is unclear whether cells in the CNS are endowed with the plasticity to reprogram. Neurons in particular are considered among the most immutable cell types, able to retain their class-specific traits for the lifespan of the organism. Here we focus on two experimental paradigms, glia-to-neuron and neuron-to-neuron conversion, to consider how lineage reprogramming has ch…

Central Nervous SystemNeuronsCell typeLineage (genetic)General Neurosciencemedia_common.quotation_subjectCentral nervous systemInduced Pluripotent Stem CellsMetamorphosis BiologicalBiologyCellular ReprogrammingArticlemedicine.anatomical_structurenervous systemmedicineAnimalsHumansEpigeneticsMetamorphosisInduced pluripotent stem cellNeuroscienceReprogrammingOrganismmedia_common
researchProduct

Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein

2022

Amyotrophic Lateral Sclerosis (ALS) is a fatal disease affecting both upper and lower motoneurons. The transactive response DNA binding protein (TARDBP) gene, encoding for TDP-43, is one of the most commonly mutated gene associated with familial cases of ALS (10%). We generated a human induced pluripotent stem cell (hiPSC) line from the fibroblasts of an asymptomatic subject carrying the TARDBP p.G376D mutation. This mutation is very rare and was described in a large Apulian family, in which all ALS affected members are carriers of the mutation. The subject here described is the first identified asymptomatic carrier of the mutation.

DNA-Binding ProteinsHeterozygoteDNA-Binding ProteinAmyotrophic Lateral SclerosisInduced Pluripotent Stem CellsMutationHumansCell BiologyGeneral MedicineInduced Pluripotent Stem CellDevelopmental BiologyAmyotrophic Lateral SclerosiHuman
researchProduct

Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion

2015

mRNA reprogramming results in the generation of genetically stable induced pluripotent stem (iPS) cells while avoiding the risks of genomic integration. Previously published mRNA reprogramming protocols have proven to be inconsistent and time-consuming and mainly restricted to fibroblasts, thereby demonstrating the need for a simple but reproducible protocol applicable to various cell types. So far there have been no published reports using mRNA to reprogram any cell type derived from human blood. Nonmodified synthetic mRNAs are immunogenic and activate cellular defense mechanisms, which can lead to cell death and inhibit mRNA translation upon repetitive transfection. Hence, to overcome RNA…

Homeobox protein NANOGCellular Reprogramming TechniquesInduced Pluripotent Stem CellsVaccinia virusFibroblastsBiologyTransfectionLIN28Molecular biologyCell biologyKruppel-Like Factor 4MicroRNAsSOX2KLF4GeneticsHumansMolecular MedicineCellular Reprogramming TechniquesRNA MessengerProgenitor cellInduced pluripotent stem cellMolecular BiologyReprogrammingEndothelial Progenitor CellsImmune EvasionHuman Gene Therapy
researchProduct

Induced Pluripotent Mesenchymal Stromal Cell Clones Retain Donor-derived Differences in DNA Methylation Profiles

2012

Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is an epigenetic phenomenon. It has been suggested that iPSC retain some tissue-specific memory whereas little is known about interindividual epigenetic variation. We have reprogrammed mesenchymal stromal cells from human bone marrow (iP-MSC) and compared their DNA methylation profiles with initial MSC and embryonic stem cells (ESCs) using high-density DNA methylation arrays covering more than 450,000 CpG sites. Overall, DNA methylation patterns of iP-MSC and ESC were similar whereas some CpG sites revealed highly significant differences, which were not related to parental MSC. Furthermore, hypermethylation in iP-MSC…

Induced Pluripotent Stem CellsBiologyDrug DiscoveryGeneticsHumansEpigeneticsCancer epigeneticsInduced pluripotent stem cellMolecular BiologyPharmacologyMesenchymal Stromal CellsReverse Transcriptase Polymerase Chain ReactionMesenchymal Stem CellsMethylationDNA MethylationFlow CytometryMolecular biologyEmbryonic stem cellImmunohistochemistryClone CellsCpG siteDNA methylationMolecular MedicineOriginal ArticleCpG IslandsReprogrammingMolecular Therapy
researchProduct

Generation of an iPSC line (UNINAi001-A) from a girl with neonatal-onset epilepsy and non-syndromic intellectual disability carrying the homozygous K…

2021

Abstract Heterozygous variants in the KCNQ3 gene cause epileptic and/or developmental disorders of varying severity. Here we describe the generation of induced pluripotent stem cells (iPSCs) from a 9-year-old girl with pharmacodependent neonatal-onset epilepsy and intellectual disability who carry a homozygous single-base duplication in exon 12 of KCNQ3 (NM_004519.3: KCNQ3 c.1599dup; KCNQ3 p.PHE534ILEfs*15), and from a non-carrier brother of the proband. For iPSC generation, non-integrating episomal plasmid vectors were used to transfect fibroblasts isolated from skin biopsies. The obtained iPSC lines had a normal karyotype, showed embryonic stem cell-like morphology, expressed pluripotency…

Male0301 basic medicineProbandQH301-705.5Induced Pluripotent Stem CellsBiology03 medical and health sciencesEpilepsyExon0302 clinical medicineIntellectual DisabilityGene duplicationIntellectual disabilitymedicineHumansBiology (General)ChildInduced pluripotent stem cellEpilepsySiblingsHomozygoteCell DifferentiationKaryotypeCell BiologyGeneral Medicinemedicine.diseaseEmbryonic stem cell030104 developmental biologyCancer researchFemale030217 neurology & neurosurgeryDevelopmental Biology
researchProduct